Mitchell S Cairo Selected Research

rasburicase (Elitek)

1/2017	A Clinical and Economic Comparison of Rasburicase and Allopurinol in the Treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome.
11/2013	Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.
10/2008	Rasburicase: future directions in tumor lysis management.
6/2008	Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
1/2005	Tumor lysis syndrome: pathophysiology, definition, and alternative treatment approaches.
1/2005	Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.
3/2003	Recombinant urate oxidase (rasburicase): a new targeted therapy for prophylaxis and treatment of patients with hematologic malignancies at risk of tumor lysis syndrome.
12/2002	Prevention and treatment of hyperuricemia in hematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitchell S Cairo Research Topics

Disease

43	Neoplasms (Cancer) 09/2021 - 02/2003
25	Lymphoma (Lymphomas) 01/2022 - 02/2003
22	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 02/2003
19	Leukemia 07/2022 - 10/2005
19	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 03/2002
19	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 03/2002
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 03/2002
13	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2020 - 10/2005
11	Hematologic Neoplasms (Hematological Malignancy) 09/2021 - 12/2002
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2022 - 07/2004
8	Infections 01/2021 - 04/2003
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015 - 09/2008
7	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 09/2011
7	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 02/2012
6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2004
6	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2020 - 04/2010
6	Tumor Lysis Syndrome 01/2017 - 12/2002
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 12/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 03/2002
5	Bronchiolitis Obliterans Syndrome 05/2015 - 04/2004
5	Thrombocytopenia (Thrombopenia) 01/2007 - 05/2002
4	Hyperuricemia 01/2017 - 12/2002
3	Ewing Sarcoma (Sarcoma, Ewing) 05/2020 - 04/2005
3	Pathologic Complete Response 01/2020 - 02/2012
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019 - 02/2010
3	Hemoglobinopathies 11/2017 - 04/2011
3	Central Nervous System Diseases (CNS Diseases) 08/2015 - 04/2007
3	Residual Neoplasm 08/2015 - 12/2004
3	Hemolysis 05/2015 - 08/2007
3	Sarcoma (Soft Tissue Sarcoma) 01/2015 - 04/2005
3	Sepsis (Septicemia) 12/2014 - 01/2002
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 02/2008
3	Skin Diseases (Skin Disease) 03/2014 - 04/2010
3	Neonatal Sepsis 01/2005 - 01/2002
2	Multiple Myeloma 09/2021 - 10/2008
2	Hemorrhage 01/2021 - 05/2002
2	Neoplasm Metastasis (Metastasis) 05/2020 - 04/2010
2	Wounds and Injuries (Trauma) 01/2020 - 03/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2013
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2017 - 10/2014
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2015 - 10/2008
2	Aplastic Anemia (Anemia, Hypoplastic) 10/2015 - 07/2014

Drug/Important Bio-Agent (IBA)

19	Rituximab (Mabthera)FDA Link 01/2022 - 09/2003
8	rasburicase (Elitek)FDA Link 01/2017 - 12/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2007
7	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 01/2005
6	Monoclonal AntibodiesIBA 09/2021 - 08/2008
6	Biological ProductsIBA 11/2018 - 01/2005
5	CytokinesIBA 01/2022 - 10/2009
5	Chimeric Antigen ReceptorsIBA 10/2020 - 09/2014
5	AntigensIBA 01/2019 - 03/2002
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 04/2004
5	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 02/2007
5	Ifosfamide FDA LinkGeneric 01/2015 - 01/2005
5	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 01/2005
5	HLA Antigens (Human Leukocyte Antigens)IBA 04/2011 - 03/2002
5	Interleukin-11 (Interleukin 11)IBA 01/2007 - 05/2002
4	Collagen Type VIIIBA 01/2018 - 04/2010
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018 - 04/2004
4	Allopurinol (Remid)FDA LinkGeneric 01/2017 - 12/2002
4	IceIBA 01/2015 - 01/2005
4	Prednisone (Sone)FDA LinkGeneric 03/2012 - 09/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2002
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2011
3	obinutuzumabIBA 08/2020 - 12/2015
3	Pharmaceutical PreparationsIBA 01/2020 - 07/2003
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 04/2007
3	Uric Acid (Urate)IBA 01/2017 - 12/2002
3	Gemtuzumab (Mylotarg)FDA Link 04/2016 - 10/2005
3	InterleukinsIBA 12/2014 - 01/2007
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2012 - 10/2008
3	Vincristine (Oncovin)FDA LinkGeneric 03/2012 - 04/2007
3	ParaffinIBA 10/2008 - 05/2003
2	LigandsIBA 01/2021 - 10/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2014
2	Granzymes (Granzyme)IBA 02/2017 - 10/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2015 - 02/2007
2	Alkylating AgentsIBA 09/2015 - 01/2015
2	AnthracyclinesIBA 09/2015 - 11/2014
2	epratuzumabIBA 07/2015 - 08/2008
2	Hemoglobins (Hemoglobin)IBA 05/2015 - 12/2014
2	Sickle HemoglobinIBA 05/2015 - 12/2014
2	Glutamic Acid (Glutamate)FDA Link 05/2015 - 12/2014
2	Valine (L-Valine)FDA Link 05/2015 - 12/2014
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2015 - 07/2008

Therapy/Procedure

40	Therapeutics 07/2022 - 02/2003
34	Transplantation 07/2022 - 03/2002
27	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
24	Stem Cell Transplantation 01/2022 - 04/2002
22	Cell Transplantation 01/2021 - 02/2008
16	Immunotherapy 01/2022 - 04/2003
15	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2004
10	Homologous Transplantation 01/2021 - 04/2006
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 03/2002
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 01/2010
2	Combination Drug Therapy (Combination Chemotherapy) 08/2020 - 03/2012
2	Aftercare (After-Treatment) 12/2017 - 11/2014
2	Length of Stay 01/2017 - 02/2008